ETKC-51

ETKC-51 is a drug used by the department to create specialized agents for the stated purpose of defending the United States of America.

History
Not much is known about this drug's composition or history, though it is the fifty-first attempt. All previous compositions were failures that resulted in the deaths of all test subjects, willing or otherwise.

In 1951, the program in charge of ETKC believed they’d finally made a breakthrough. They rounded up soldiers who seemed exceptionally stubborn, or exceptionally lucky. Of that original group, they narrowed it down to fifty men.

Twenty received a single dose of ETKC-51. Twenty others received a double dose, and the final ten men, acting as a control group, got nothing.

Application
Subjects are given a single dose of the drug, though not all survive the process, a ratio that stands at 50/50. If two doses are given, the subject becomes uncontrollable and dies within two to three weeks.

ETKC-51 is inheritable, as proven by the Whetū children fathered by Django Whetū, further expressed in his granddaughter, Neumia de Lacy.

Effects
The exact enhancements provided by the drug are unspecific and widely varied, ranging from slight precognition (Kai ‘Aukai) to dream-sharing (Rex Tjin and Euan Ambrus) to calling lightning (Django Whetū) or surviving seemingly deadly wounds (Khodī̂ Som). Often these are family traits, enhanced a great degree by ETKC-51; the drug's expression is considered unique to the individual subject.

Every person treated with a successful dose of ETKC-51 has shown a greatly reduced age rate upon reaching adulthood, possibly based upon cellular regrowth and renewal.